首页|哌拉西林/他唑巴坦治疗泌尿系统感染的疗效分析

哌拉西林/他唑巴坦治疗泌尿系统感染的疗效分析

扫码查看
目的 探讨泌尿系统感染应用哌拉西林/他唑巴坦治疗的效果。方法 75 例泌尿系统感染患者,依照治疗方案的不同分为对照组(28 例)和研究组(47 例)。对照组采用左氧氟沙星治疗,研究组采用哌拉西林/他唑巴坦治疗。对比两组疗效、细菌清除率及不良反应发生率。结果 研究组总有效率 91。5%较对照组的 71。4%高(P<0。05)。研究组菌株为 37 株,对照组为 21 株,研究组细菌清除率86。5%(32/37)与对照组的85。7%(18/21)对比无差异(P>0。05)。研究组不良反应发生率4。3%与对照组的3。6%对比无差异(P>0。05)。结论 在泌尿系统感染中,哌拉西林/他唑巴坦治疗效果好,且安全性较高,值得应用与推广。
Efficacy analysis of piperacillin/tazobactam in the treatment of urinary system infection
Objective To explore the effect of piperacillin/tazobactam in the treatment of urinary system infection.Methods 75 patients with urinary tract infection were divided into a control group(28 cases)and a study group(47 cases)according to different treatment plans.The control group was treated with levofloxacin,and the study group was treated with piperacillin/tazobactam.The clinical efficacy,bacterial clearance rate and adverse reactions of the two groups were compared.Results The total effective rate of the study group was 91.5%,which was higher than 71.4%of the control group(P<0.05).There were 37 strains in the study group and 21 strains in the control group.The bacterial clearance rate in the study group was 86.5%(32/37),which was not different from 85.7%(18/21)in the control group(P>0.05).There was no difference in the incidence of adverse reactions between the study group(4.3%)and the control group(3.6%)(P>0.05).Conclusion Piperacillin/tazobactam is effective and safe in the treatment of urinary system infection,which is worthy of application and promotion.

Urinary system infectionPiperacillin/tazobactamClinical efficacyAdverse reactions

洪建兴、施巧微

展开 >

362200 晋江市医院晋南分院肾内科

362200 晋江市医院手术室

泌尿系统感染 哌拉西林/他唑巴坦 临床疗效 不良反应

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(11)